Heptares Therapeutics
Kaan Harwood started working at Sosei Heptares in July 2019 as an Analytical Scientist. Prior to that, in September 2017, Kaan began working as an Industrial Placement Student - Medicinal Chemist at GSK. The placement at GSK ended in August 2018.
Kaan Harwood completed their Master of Science degree in Chemistry at The University of Sheffield from 2016 to 2019. Prior to that, they pursued their first Master of Science degree in Chemistry at the University of Oxford from 2013 to 2015.
Heptares Therapeutics
Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, StabilisedReceptors), overcoming a major limiting factor to the development of new drugs targeting this group.